Cassandra Pardini, PharmD

Contributing Writer

Cassandra Pardini is a freelance writer and registered pharmacist with a diverse background in drug therapy, scientific research, and the drug discovery and developmental process. She obtained her Doctor of Pharmacy degree from the Massachusetts College of Pharmacy and Health Sciences University, Master of Science degree in chemistry and chemical biology from Northeastern University, and Bachelor of Science degree in chemistry from Boston College. She currently lives in Rhode Island with her husband and 3 children.

All articles by Cassandra Pardini, PharmD

Case Studies

Antidepressant, NSAID Identified as Culprits in SIADH Case

Cassandra Pardini, PharmD

September 24, 2020

The patient noted that she was initiated on naproxen by her primary care physician 2 weeks prior to her presentation.

General Pain

Supplements With Undeclared Active Ingredients Pose Substantial Health Risk

Cassandra Pardini, PharmD

June 30, 2020

A recent Morbidity and Mortality Weekly Report highlights the risks associated with use of OTC products containing undeclared prescription ingredients as well as the importance of collaboration between various health departments and systems to ensure a prompt response to an outbreak.

General Pain

Evidence Supporting Dietary Supplement Use for COVID-19 Lacking

Cassandra Pardini, PharmD

May 29, 2020

There is a lack of evidence supporting the use of dietary supplements for the prevention or treatment of COVID-19, despite what recent news or social media platforms have asserted,

General Pain

Evidence Supporting Use of Compounded Topical Pain Creams Limited

Cassandra Pardini, PharmD

May 26, 2020

“In context of the recent rise in supply and demand of compounded preparations, lack of evidence regarding systemic absorption of ingredients used in compounded topical pain creams gives rise to a substantial public health concern,” the authors concluded.

General Pain

Guidance Issued on Managing Pain During Public Health Crises

Cassandra Pardini, PharmD

April 14, 2020

In order to provide national guidance addressing issues surrounding pain management practices, an expert panel was convened to provide a framework for pain practitioners and institutions.

Migraine & Headache

Meloxicam/Rizatriptan Combination Superior to Placebo in Migraine Trial

Cassandra Pardini, PharmD

April 9, 2020

Treatment with AXS-07, an investigational therapy being developed by Axsome Therapeutics, substantially reduced migraine pain and significantly prevented the progression of migraine pain intensity, according to results of the phase 3 INTERCEPT trial.

Migraine & Headache

Drug Therapies Evaluated for Pediatric Migraine Prophylaxis

Cassandra Pardini, PharmD

March 13, 2020

There is limited evidence supporting the prophylactic use of pharmacological therapies for the prevention of migraine in pediatric patients, according to the findings of a recently published systematic review and network meta-analysis.

General Pain

Case Series: Low-Dose Naltrexone for Chronic Fatigue Syndrome

Cassandra Pardini, PharmD

February 11, 2020

The use of low-dose naltrexone (LDN) to treat chronic fatigue syndrome was described in a recent case series published in BMJ Case Reports.

General Pain

Proper Citation of Retracted Articles: An Analysis of the Wakefield Paper

Cassandra Pardini, PharmD

December 27, 2019

Findings of a recently published cross-sectional bibliographic analysis reveal that most citations of the 1998 research study published by Wakefield et al, which fraudulently associated the measles-mumps-rubella vaccine with autism, were considered negative, however a significant number of articles did not include mention of the paper’s retraction. To evaluate the characteristics of the scholarly literature…

Next post in General Pain